Proteomics International ENGAGES ABCAM, TO MANUFACTURE PROMARKERD REAGENTS
- Global life science company Abcam plc engaged to produce reagents for Proteomics International’s immunoassay version of the PromarkerD test for diabetic kidney disease - Abcam is a leader in the supply of life science research tools and reagents, including supply to companies who develop and market diagnostic solutions around the world - Working with Abcam will help streamline test production, allowing Proteomics International to service anticipated demand for PromarkerD worldwide - The engagement signifies Proteomics International achieving another milestone as it continues the path towards commercialisation of PromarkerD in global markets https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02397875-6A1041888?access_token=83ff96335c2d45a094df02a206a39ff4
PIQ Price at posting:
$1.02 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)